CAIRO - 13 July 2022: Egypt's Holding Company for Biological Products and Vaccines "Vacsera" is proceeding to localize the pharmaceutical industry in the country, according to the directives of the political leadership, said Chairman of the Board of Directors Dr. Heba Wali. Dr. Wali noted that the authority is seeking to put Egypt on the map of the global pharmaceutical market, through pharmaceutical manufacturing investments. In this regard, she added that two factories are currently being established for human and veterinary vaccines. The Vacsera factory complex, located in October city, is scheduled to produce 400 million doses of veterinary vaccines for bird flu, in addition to 7 other vaccines related to animal production. The complex can produce 300 million doses of human vaccines, including Corona vaccines, through a factory and a line Production of human vaccines packaging, she added.

Source: Egypt Today July 13, 2022 12:25 UTC